Crossmark

Critical appraisal of modified robot-assisted segmentectomy in early-stage non–small cell lung cancer: balancing peri-operative benefits with oncologic rigor and cost considerations

Crossref DOI link: https://doi.org/10.1007/s11701-025-02690-x

Published Online: 2025-08-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khan, Suleman https://orcid.org/0009-0006-6486-3093
Shah, Asim
License Information

Text and Data Mining valid from 2025-08-28

Version of Record valid from 2025-08-28
More Information

Article History

Received: 9 August 2025

Accepted: 17 August 2025

First Online: 28 August 2025

Declarations

:

: The authors declare no competing interests.

: This study did not include any patients, so ethical approval was not necessary.

Document is current

Any future updates will be listed below